Docteur Michel ROLLAND

Bibliographie

• Vascular and blood-brain barrier-related changes underlie stress responses and resilience in female mice and depression in human tissue

  2022

  ArticleNature Communications

• COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

  2021

  ArticleThe Lancet Rheumatology

• Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients

  2020

  ArticleAnnals of the Rheumatic Diseases

• Analyse systémique des tendances e-comportementales, induites par les Technologies de l'Information et de la Communication en management à distance

  2010

  Thèse

Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).

Lieu de consultation

Tarifs & secteur de conventionnement

Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).

Prendre rendez-vous & contact

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Articles de presse (3)

Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).

• Michel Rolland: son horizon c’était six mois, aujourd'hui il s'éclate - Charente Libre

  📰 Charente Libre · 09/10/2017

  <a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxNSndUeTRfeXhRNEYteTM0ZmRlLW1SQ0tkZ0h2WjE1aUtkaWJsX0ZNTkIwODBCSnB0UU1CN2xoQUtJRHVuOGU4UmFMVnZPMW5va3o5QlI3RGxZSm5OS0tyTElaakFwZF9zMXVqQ1E3THBPTDdrNDBPSUsyYlh6UHhCMERlTUVlZm9kamtlclJuRC1yTGJ5dzNjNUlHZm52akpZWVNEaWdpS2ljUmlPdGY5aVJQUVE?oc=5"

• Le célèbre œnologue français Michel Rolland s’est éteint - La Presse

  📰 La Presse · 20/03/2026

  <a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxQLWJQNjUxT1JPeXR1Y3J4MlZrUmpsenpaRDJlUjZLaEE0Z3RuZkNCcldUMExEZF9nMjl3TGhIMmUyNVpQUktmaXFtUWE5enIzOExKYlo3YXByZVRBeXlLY2hDdlJRZjdsOF9wRy1FNUotbG9mbjY3RjJHSE5EbDBISnN3TFlMeXVSbWZQdXE4REM0UUxFcTFPOFRYREhXMjNDRjRQX0xxRWRKVWwyT2xwUFdPdw?oc=5" t

• Cinq questions à Dany Rolland - La Presse

  📰 La Presse · 10/02/2013

  <a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxNNW5MeUJUTnlSNV85bTI1ZnI3YmVzWjU4MFpyX2huc1MwWXczZ2w0QUJOOUFiU1JndHc3aEEtV2ZSVDhxMnVHQkhkdnRIVFRUVEJ6aS12cG9mMHBMRkMzYVRIanpqRE53anNVYVQ2OTZKaWtFbUI0VVNDUWV5eThxTk1LQ19MOWhiMWQ0RjJnVy01RXpuZVFEaVBn?oc=5" target="_blank">Cinq questions à Da

Top publications · les plus citées

• 1

  Reference range for micronutrients and nutritional marker proteins in cord blood of neonates appropriated for gestational ages

  Early human development · 2005

  📚 54 citations🎯 RCR 1.91
• 2

  Molecular characterization and phylogenetic study of Maedi Visna and Caprine Arthritis Encephalitis viral sequences in sheep and goats from Spain

  Virus research · 2006

  📚 50 citations🎯 RCR 1.83
• 3

  Patterns of prednisone use during pregnancy in women with rheumatoid arthritis: Daily and cumulative dose

  Pharmacoepidemiology and drug safety · 2018

  📚 49 citations🎯 RCR 2.78Top 18% NIH

  Lire l'abstract Crossref ↓

  AbstractPurposeTo characterize prednisone use in pregnant women with rheumatoid arthritis using individual‐level heat‐maps and clustering individual trajectories of prednisone dose, and to evaluate the association between prednisone dose trajectory groups and gestational length.MethodsThis study included pregnant women with rheumatoid arthritis who enrolled in the MotherToBaby Autoimmune Diseases in Pregnancy Study (2003–2014) before gestational week 20 and reported prednisone use without another oral glucocorticoid during pregnancy (n = 254). Information on medication use and pregnancy outcomes was collected by telephone interview plus by medical record review. Prednisone daily dose and cumulative dose were plotted by gestational day using a heat map for each individual. K‐means clustering was used to cluster individual trajectories of prednisone dose into groups. The associations between trajectory group and demographics, disease severity measured by the Health Assessment Questionnaire at enrollment, and gestational length were evaluated.ResultsWomen used prednisone 3 to 292 days during pregnancy, with daily doses ranging from &lt;1 to 60 mg. Total cumulative dose ranged from 8 to 6225 mg. Disease severity, non‐biologic disease modifying anti‐rheumatic drug use, and gestational length varied significantly by trajectory group. After adjusting for disease severity, non‐biologic disease modifying anti‐rheumatic drug use, and other covariates, the highest vs lowest daily dose trajectory group was associated with reduced gestational age at delivery (β: −2.3 weeks (95%: −3.4, −1.3)), as was the highest vs lowest cumulative dose trajectory group (β: −2.6 weeks (95%: −3.6, −1.5)).ConclusionsIn pregnant women with rheumatoid arthritis, patterns of higher prednisone dose were associated with shorter gestational length compared with lower dose.

Publications scientifiques (10) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Partager cette fiche